PIRAMAL PHARMA
|
PIRAMAL PHARMA Last 5 Year Balance Sheet History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹1,327 Cr | ₹1,324 Cr | ₹1,323 Cr | ₹1,193 Cr | ₹1,186 Cr |
| Equity - Authorised | ₹2,629 Cr | ₹2,629 Cr | ₹2,629 Cr | ₹2,629 Cr | ₹1,500 Cr |
| Equity - Issued | ₹1,327 Cr | ₹1,324 Cr | ₹1,323 Cr | ₹1,193 Cr | ₹1,186 Cr |
| Equity Paid Up | ₹1,327 Cr | ₹1,324 Cr | ₹1,323 Cr | ₹1,193 Cr | ₹1,186 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | ₹73 Cr | ₹62 Cr | ₹27 Cr | - | - |
| Total Reserves | ₹6,763 Cr | ₹6,739 Cr | ₹6,561 Cr | ₹5,580 Cr | ₹5,511 Cr |
| Securities Premium | ₹4,768 Cr | ₹4,737 Cr | ₹4,725 Cr | ₹3,819 Cr | ₹3,725 Cr |
| Capital Reserves | ₹407 Cr | ₹407 Cr | ₹407 Cr | ₹407 Cr | ₹407 Cr |
| Profit & Loss Account Balance | ₹692 Cr | ₹1,049 Cr | ₹971 Cr | ₹956 Cr | ₹1,159 Cr |
| General Reserves | ₹3.22 Cr | ₹1.05 Cr | - | - | - |
| Other Reserves | ₹893 Cr | ₹545 Cr | ₹459 Cr | ₹398 Cr | ₹220 Cr |
| Reserve excluding Revaluation Reserve | ₹6,763 Cr | ₹6,739 Cr | ₹6,561 Cr | ₹5,580 Cr | ₹5,511 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹8,163 Cr | ₹8,125 Cr | ₹7,911 Cr | ₹6,774 Cr | ₹6,697 Cr |
| Minority Interest | - | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | ₹4,300 Cr | ₹3,214 Cr | ₹2,484 Cr | ₹3,384 Cr | ₹2,622 Cr |
| Non Convertible Debentures | - | - | ₹100 Cr | ₹399 Cr | ₹199 Cr |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | ₹421 Cr | ₹357 Cr | ₹264 Cr | ₹294 Cr | ₹278 Cr |
| Term Loans - Institutions | ₹3,879 Cr | ₹2,857 Cr | ₹2,120 Cr | ₹2,691 Cr | ₹2,145 Cr |
| Other Secured | - | - | - | - | - |
| Unsecured Loans | - | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹-157 Cr | ₹-145 Cr | ₹-157 Cr | ₹-130 Cr | ₹-105 Cr |
| Deferred Tax Assets | ₹710 Cr | ₹612 Cr | ₹601 Cr | ₹471 Cr | ₹406 Cr |
| Deferred Tax Liability | ₹554 Cr | ₹468 Cr | ₹443 Cr | ₹341 Cr | ₹301 Cr |
| Other Long Term Liabilities | ₹292 Cr | ₹275 Cr | ₹286 Cr | ₹282 Cr | ₹240 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹94 Cr | ₹49 Cr | ₹32 Cr | ₹276 Cr | ₹145 Cr |
| Total Non-Current Liabilities | ₹4,529 Cr | ₹3,393 Cr | ₹2,645 Cr | ₹3,812 Cr | ₹2,903 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹2,479 Cr | ₹1,534 Cr | ₹1,538 Cr | ₹1,193 Cr | ₹1,026 Cr |
| Sundry Creditors | ₹2,479 Cr | ₹1,534 Cr | ₹1,538 Cr | ₹1,193 Cr | ₹1,026 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹1,479 Cr | ₹1,185 Cr | ₹1,576 Cr | ₹1,305 Cr | ₹1,243 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹505 Cr | ₹223 Cr | ₹344 Cr | ₹117 Cr | ₹140 Cr |
| Interest Accrued But Not Due | - | - | - | - | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹974 Cr | ₹961 Cr | ₹1,232 Cr | ₹1,188 Cr | ₹1,103 Cr |
| Short Term Borrowings | ₹748 Cr | ₹995 Cr | ₹1,171 Cr | ₹1,302 Cr | ₹659 Cr |
| Secured ST Loans repayable on Demands | ₹723 Cr | ₹949 Cr | ₹1,149 Cr | ₹1,295 Cr | ₹617 Cr |
| Working Capital Loans- Sec | ₹723 Cr | ₹884 Cr | ₹1,019 Cr | ₹1,295 Cr | ₹617 Cr |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹-697 Cr | ₹-838 Cr | ₹-996 Cr | ₹-1,287 Cr | ₹-575 Cr |
| Short Term Provisions | ₹169 Cr | ₹137 Cr | ₹84 Cr | ₹51 Cr | ₹190 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹127 Cr | ₹94 Cr | ₹40 Cr | ₹12 Cr | ₹156 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹42 Cr | ₹43 Cr | ₹44 Cr | ₹39 Cr | ₹34 Cr |
| Total Current Liabilities | ₹4,875 Cr | ₹3,851 Cr | ₹4,369 Cr | ₹3,851 Cr | ₹3,118 Cr |
| Total Liabilities | ₹17,567 Cr | ₹15,369 Cr | ₹14,925 Cr | ₹14,437 Cr | ₹12,717 Cr |
| ASSETS | |||||
| Gross Block | ₹14,905 Cr | ₹13,118 Cr | ₹12,137 Cr | ₹10,842 Cr | ₹9,510 Cr |
| Less: Accumulated Depreciation | ₹6,214 Cr | ₹4,984 Cr | ₹4,148 Cr | ₹3,374 Cr | ₹2,631 Cr |
| Less: Impairment of Assets | ₹7.10 Cr | - | - | - | - |
| Net Block | ₹8,684 Cr | ₹8,133 Cr | ₹7,990 Cr | ₹7,469 Cr | ₹6,879 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹799 Cr | ₹489 Cr | ₹566 Cr | ₹853 Cr | ₹673 Cr |
| Non Current Investments | ₹305 Cr | ₹271 Cr | ₹240 Cr | ₹212 Cr | ₹217 Cr |
| Long Term Investment | ₹305 Cr | ₹271 Cr | ₹240 Cr | ₹212 Cr | ₹217 Cr |
| Quoted | ₹0.03 Cr | ₹0.05 Cr | - | - | - |
| Unquoted | ₹307 Cr | ₹273 Cr | ₹242 Cr | ₹212 Cr | ₹217 Cr |
| Long Term Loans & Advances | ₹155 Cr | ₹91 Cr | ₹115 Cr | ₹494 Cr | ₹297 Cr |
| Other Non Current Assets | ₹15 Cr | ₹15 Cr | - | ₹0.04 Cr | ₹0.04 Cr |
| Total Non-Current Assets | ₹10,259 Cr | ₹9,487 Cr | ₹9,461 Cr | ₹9,593 Cr | ₹8,565 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹132 Cr | ₹20 Cr | ₹145 Cr | ₹427 Cr | ₹50 Cr |
| Quoted | ₹132 Cr | ₹20 Cr | ₹145 Cr | ₹413 Cr | ₹37 Cr |
| Unquoted | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹13 Cr |
| Inventories | ₹3,064 Cr | ₹2,313 Cr | ₹2,176 Cr | ₹1,681 Cr | ₹1,389 Cr |
| Raw Materials | ₹1,458 Cr | ₹936 Cr | ₹1,022 Cr | ₹728 Cr | ₹599 Cr |
| Work-in Progress | ₹657 Cr | ₹624 Cr | ₹526 Cr | ₹335 Cr | ₹322 Cr |
| Finished Goods | ₹374 Cr | ₹241 Cr | ₹186 Cr | ₹247 Cr | ₹98 Cr |
| Packing Materials | - | - | - | - | - |
| Stores  and Spare | ₹198 Cr | ₹156 Cr | ₹175 Cr | ₹172 Cr | ₹122 Cr |
| Other Inventory | ₹378 Cr | ₹356 Cr | ₹267 Cr | ₹199 Cr | ₹247 Cr |
| Sundry Debtors | ₹2,158 Cr | ₹2,350 Cr | ₹2,134 Cr | ₹1,799 Cr | ₹1,785 Cr |
| Debtors more than Six months | ₹178 Cr | ₹154 Cr | ₹162 Cr | ₹127 Cr | ₹86 Cr |
| Debtors Others | ₹2,075 Cr | ₹2,293 Cr | ₹2,083 Cr | ₹1,775 Cr | ₹1,754 Cr |
| Cash and Bank | ₹1,224 Cr | ₹501 Cr | ₹483 Cr | ₹308 Cr | ₹329 Cr |
| Cash in hand | ₹2.47 Cr | ₹1.99 Cr | ₹1.79 Cr | ₹2.21 Cr | ₹0.09 Cr |
| Balances at Bank | ₹1,085 Cr | ₹476 Cr | ₹459 Cr | ₹305 Cr | ₹306 Cr |
| Other cash and bank balances | ₹137 Cr | ₹23 Cr | ₹22 Cr | - | ₹22 Cr |
| Other Current Assets | ₹145 Cr | ₹135 Cr | ₹82 Cr | ₹140 Cr | ₹94 Cr |
| Interest accrued on Investments | - | - | - | - | - |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | ₹1.52 Cr | ₹1.10 Cr | ₹0.76 Cr | ₹2.20 Cr | ₹0.29 Cr |
| Prepaid Expenses | ₹98 Cr | ₹79 Cr | ₹64 Cr | ₹77 Cr | ₹70 Cr |
| Other current_assets | ₹46 Cr | ₹55 Cr | ₹17 Cr | ₹61 Cr | ₹24 Cr |
| Short Term Loans and Advances | ₹586 Cr | ₹563 Cr | ₹445 Cr | ₹488 Cr | ₹505 Cr |
| Advances recoverable in cash or in kind | ₹240 Cr | ₹167 Cr | ₹121 Cr | ₹146 Cr | ₹156 Cr |
| Advance income tax and TDS | ₹116 Cr | ₹91 Cr | ₹1.24 Cr | ₹7.99 Cr | ₹85 Cr |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹229 Cr | ₹306 Cr | ₹323 Cr | ₹334 Cr | ₹264 Cr |
| Total Current Assets | ₹7,308 Cr | ₹5,881 Cr | ₹5,464 Cr | ₹4,843 Cr | ₹4,152 Cr |
| Net Current Assets (Including Current Investments) | ₹2,433 Cr | ₹2,031 Cr | ₹1,095 Cr | ₹992 Cr | ₹1,034 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹17,567 Cr | ₹15,369 Cr | ₹14,925 Cr | ₹14,437 Cr | ₹12,717 Cr |
| Contingent Liabilities | ₹96 Cr | ₹100 Cr | ₹61 Cr | ₹57 Cr | ₹45 Cr |
| Total Debt | ₹5,495 Cr | ₹4,720 Cr | ₹4,559 Cr | ₹5,505 Cr | ₹4,023 Cr |
| Book Value | 60.96 | 60.89 | 59.59 | 56.76 | 56.47 |
| Adjusted Book Value | 60.96 | 60.89 | 59.59 | 55.44 | 55.15 |
Compare Balance Sheet of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹23,683.8 Cr | 5.8% | 4.9% | -13.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 5.8% |
4.9% |
-13.3% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses